Bioneer Corporation (KOSDAQ: 064550)

Market Cap	491.17B
Revenue (ttm)	287.66B
Net Income (ttm)	-26.66B
Shares Out	25.81M
EPS (ttm)	-1,032.73
PE Ratio	n/a
Forward PE	12.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,813
Open	19,960
Previous Close	20,300
Day's Range	19,500 - 20,150
52-Week Range	17,610 - 39,100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 18, 2025

About Bioneer

Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, a...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1992
• Employees: 562
• Stock Exchange: KOSDAQ
• Ticker Symbol: 064550